Ochronosis/Alkaptonuria
Inborn error of tyrosine metabolism
Autosomal recessive mutation of HGD (Homogentisic acid),
at least 203 variants
1:250,000 to 1:1,000,000, higher in Dominican Republic
and Slovakia
Pathogenesis: yellow
Presentation: blue
Labs/Image: red
Histopathology: magenta
Treatment : green
Extra: gray
Typical triad (urine, cutaneous, arthritis)
High levels of HGA and its oxidized
byproducts can affect collagen
crosslinking, leading to increased cartilage
stiffness and structural weakness
First early sign
Dark urine upon oxidation or alkalization
21% were diagnosed before 1 yo
Ochronotic arthropathy
(later signs)
3rd decade of life
Peripheral: knee (64%) > shoulders (43%)
> hip/pelvis (35%); tendon,
enthesopathy, in 50-60s
Axial: lumbar, thoracic > cervical (spares SI), mimic AS,
usually in 30-40s
Typical radiographic findings (broad syndesmophytes, dense
wafer- like disc calcification, vacuum phenomenom
Aortic or mitral valve
calcification was detected
at a mean age of 54
24-hour urinary excretion of HGA
plasma homogentisate level
DNA testing for genetic
mutations of the HGD gene
25% has elevated ESR
ochronotic pigmentation,
thickened synovium with
synovitis, and reactive
giant cells, pigment
containing macrophages
Nitisinone (Orfadin) => reduce
plasma and urine HGA by 95%